newsfilter
← Earnings
Earnings Releases·

Precipio — Q3-2026 Earnings Summary

Precipio, Inc. reported third-quarter 2026 revenue of $7.3 million, representing an 8% year-over-year increase driven by growth in both product and pathology segments. The company achieved positive Adjusted EBITDA of $0.4 million and generated $0.6 million in cash flow from operations, resulting in an end-of-quarter cash balance exceeding $3.5 million. CEO Ilan Danieli stated that these financial results position the specialty cancer diagnostics firm to accelerate the commercialization of its existing product portfolio. The company plans to discuss these results in detail during a shareholder call scheduled for 5 PM ET on the day of the announcement.

Company
PRECIPIO INC
Sector
Healthcare
Industry
Diagnostics & Research